Impilo completed the acquisition of VaccinDirekt from SEB Private Equity.

Impilo, a private equity firm, completed the acquisition of VaccinDirekt, a vaccination provider, from SEB Private Equity, a private equity firm. Financial terms were not disclosed. “VaccinDirekt is the leading vaccination provider in a winning channel enjoying strong underlying growth, primarily driven by increased public awareness for vaccines, the enhanced focus on preventive healthcare, and a steadily growing pipeline of new vaccines. The Company is well-positioned to extend its leadership, leveraging its unparalleled quality, know-how, and customer focus, coupled with a large physical footprint in central locations, offering superior convenience and availability to its growing base of more than 1.4m registered customers. As a long-term and dedicated healthcare investor, Impilo is excited to support VaccinDirekt in driving a customer focused expansion of the platform as the Company continues to increase availability of high-quality preventive healthcare services in the Nordics," Victor Steien, Impilo Partner.